Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03091733

Ligand	Ligand name	Chain	PDB	Tanimoto
STR	PROGESTERONE	A	1H60	0.7
STR	PROGESTERONE	A,B,C	1YA3	0.7
STR	PROGESTERONE	A,B	2AA6	0.7
STR	PROGESTERONE	A	1MRQ	0.7
STR	PROGESTERONE	A,B	1A28	0.7
STR	PROGESTERONE	A,B	2AA5	0.7
STR	PROGESTERONE	A	2HZQ	0.7
STR	PROGESTERONE	A	1W0F	0.7
STR	PROGESTERONE	A	2ABA	0.7
STR	PROGESTERONE	A,B	3COT	0.7
STR	PROGESTERONE	H	1DBB	0.7
STR	PROGESTERONE	H,L	2O5Y	0.7
CBO	CARBENOXOLONE	A,B,C,D	1HDC	0.73
CBO	CARBENOXOLONE	A,B,C,D	2BEL	0.73
TES	TESTOSTERONE	A	1JTV	0.77
TES	TESTOSTERONE	A	2Q7L	0.77
TES	TESTOSTERONE	A	2Q7I	0.77
TES	TESTOSTERONE	A,B	1J96	0.77
TES	TESTOSTERONE	A	2Q7K	0.77
TES	TESTOSTERONE	A,B	1Q13	0.77
TES	TESTOSTERONE	H	1I9J	0.77
TES	TESTOSTERONE	A,B	1AFS	0.77
TES	TESTOSTERONE	H	1VPO	0.77
TES	TESTOSTERONE	A	2Q7J	0.77
TES	TESTOSTERONE	A,B	3BUR	0.77
TES	TESTOSTERONE	A	2AM9	0.77
FUA	FUSIDIC ACID	A	1QCA	0.7
FUA	FUSIDIC ACID	A,B,C,D,E,F,G,H,I,J,K,L	1Q23	0.7
FUA	FUSIDIC ACID	A,B	2VUF	0.7
17H	17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE	A	2AMB	0.73
GA3	GIBBERELLIN A3	A	2ZSH	0.73
GA3	GIBBERELLIN A3	A,B,C,D,E,F	3ED1	0.73
SIH	PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE	H	1DBM	0.81
HYF	4-HYDROXY-5-ISOBUTYRYL-6-METHYL-1,3,7-TRIS-(3-METHYL-BUT-2-ENYL)-6-(4-METHYL-PENT-3-ENYL)-BICYCLO[3.3.1]NON-3-ENE-2,9-DIONE	A	1M13	0.71
20E	(2beta,3beta,5beta,22R)-2,3,14,20,22,25-hexahydroxycholest-7-en-6-one	A,D	2R40	0.72
GR3	3-ACETOXY-17-(1-FORMYL-5-METHYL-3-OXO-HEX-4-ENYL)-16-HYDROXY-4,10,13,14-TETRAMETHYL-2,3,4,5,6,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-4-CARBOXYLIC ACID	B,D	1AWH	0.75
SNL	SPIRONOLACTONE	A,B	2AB2	0.72
SNL	SPIRONOLACTONE	A,B,C,D,E,F	2OAX	0.72
AS4	ALDOSTERONE	A	2AA2	0.77
AS4	ALDOSTERONE	A	2Q1H	0.77
DEX	DEXAMETHASONE	A,D	1M2Z	0.71
DEX	DEXAMETHASONE	A,B,C,D	1P93	0.71
GA4	GIBBERELLIN A4	A	2ZSI	0.7
GA4	GIBBERELLIN A4	A,B,C,D,E,F	3EBL	0.7
GA4	GIBBERELLIN A4	H,I	1KFA	0.7
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A,B	1E3R	0.73
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	3DHE	0.73
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1J99	0.73
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1COY	0.73
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1Q22	0.73
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EAU	0.74
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EB3	0.74
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EB4	0.74
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A,B	2AAX	0.74
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	1H61	0.74
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A,B	3CMF	0.74
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	2Q1V	0.74
NTH	SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER	A,B	1BUQ	0.82
PLO	(3BETA)-3-HYDROXYPREGN-5-EN-20-ONE	A	1Q20	0.72
1CA	DESOXYCORTICOSTERONE	A,B	1Y9R	0.76
1CA	DESOXYCORTICOSTERONE	A,B,C	2ABI	0.76
1CA	DESOXYCORTICOSTERONE	A	2Q3Y	0.76
1CA	DESOXYCORTICOSTERONE	A	2AA7	0.76
DL4	(14beta,17alpha,25R)-3-oxocholest-4-en-26-oic acid	A	3GYT	0.82
HCY	(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione	A,B	2VDY	0.74
HCY	(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione	A	2V95	0.74
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPG	0.77
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPJ	0.77
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPF	0.77
TH2	TESTOSTERONE HEMISUCCINATE	A,B	2CBT	0.81
TH2	TESTOSTERONE HEMISUCCINATE	A,B,C,D,E,F	2CBQ	0.81
TH2	TESTOSTERONE HEMISUCCINATE	A	2CBO	0.81
ASD	4-ANDROSTENE-3-17-DIONE	A,B	3CAS	0.7
ASD	4-ANDROSTENE-3-17-DIONE	A	1QYX	0.7
ASD	4-ANDROSTENE-3-17-DIONE	A,B,C,D	2VCT	0.7
ASD	4-ANDROSTENE-3-17-DIONE	A	1EUP	0.7
ASD	4-ANDROSTENE-3-17-DIONE	A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P	2VCV	0.7
ASD	4-ANDROSTENE-3-17-DIONE	A	3EQM	0.7
ASD	4-ANDROSTENE-3-17-DIONE	A	1XF0	0.7
ZK5	9ALPHA-FLUOROCORTISOL	A	1GS4	0.73
C0R	CORTICOSTERONE	A	2A3I	0.77
C0R	CORTICOSTERONE	A,B	1Y5R	0.77
DL7	(5beta,14beta,17alpha,25R)-3-oxocholest-7-en-26-oic acid	A	3GYU	0.78
CBW	(3BETA,5BETA,14BETA)-3-HYDROXY-11-OXOOLEAN-12-EN-29-OIC ACID	A	2W4Q	0.73
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	A,D	1R1K	0.72
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	E,U	1Z5X	0.72
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	E,F,G,H	2NXX	0.72
NDR	(14beta,17alpha)-17-ethynyl-17-hydroxyestr-4-en-3-one	A,B	1SQN	0.76
NDR	(14beta,17alpha)-17-ethynyl-17-hydroxyestr-4-en-3-one	A,B	2W8Y	0.76
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	1E3G	0.73
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A,B	1E3K	0.73
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	2AO6	0.73
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	1XOW	0.73
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	1XQ3	0.73
NOG	13-BETA-ETHYL-17-ALPHA-ETHYNYL-17-BETA-HYDROXYGON-4-EN-3-ONE	A	1LHV	0.76
NOG	13-BETA-ETHYL-17-ALPHA-ETHYNYL-17-BETA-HYDROXYGON-4-EN-3-ONE	A,B	3D90	0.76